Vathany Kulasingam, PhD

Dr. Kulasingam's laboratory is focusing on using high-throughput “omics” technologies to understand disease pathogenesis, with a particular emphasis on cancer and rheumatic diseases and its application to clinical practice.

 

J Clin Pathol. 2019 Nov 05;:
Fung AWS, Sugumar V, Ren AH, Kulasingam V
J Appl Lab Med. 2019 Oct 29;:
Taher J, Chen C, Kulasingam V
J Appl Lab Med. 2019 09;4(2):270-273
Parker ML, Stefan C, Reich HN, Kulasingam V
F1000Res. 2018;7:189
Leung F, Bernardini MQ, Liang K, Batruch I, Rouzbahman M, Diamandis EP, Kulasingam V
NPJ Precis Oncol. 2017;1(1):17
Kulasingam V, Prassas I, Diamandis EP
F1000Res. 2017;6:1832
Fung AWS, Knauer MJ, Blasutig IM, Colantonio DA, Kulasingam V
Am J Physiol Renal Physiol. 2017 Aug 01;313(2):F184-F191
Rajasekeran H, Lytvyn Y, Bozovic A, Lovshin JA, Diamandis E, Cattran D, Husain M, Perkins BA, Advani A, Reich HN, Kulasingam V, Cherney DZI
Clin Chem. 2016 12;62(12):1556-1564
White Al-Habeeb N, Kulasingam V, Diamandis EP, Yousef GM, Tsongalis GJ, Vermeulen L, Zhu Z, Kamel-Reid S

Pages


Deputy Head, Clinical Biochemistry, University Health Network
Associate Professor, Laboratory Medicine & Pathobiology, University of Toronto